| Literature DB >> 26859083 |
Paola Mapelli1, Elena Incerti, Federico Fallanca, Luigi Gianolli, Maria Picchio.
Abstract
Ovarian cancer represents one of the major form of cancer in women in the western world and its silent nature leads to a late clinical manifestation at advanced stage in many patients. Therefore the role of imaging techniques is very important for the correct management of these patients. In the present review, the role of 18F-FDG-PET/CT in the different clinical settings is presented and a comparison with other imaging modalities and serum biomarker CA-125 are discussed.Entities:
Mesh：
Substances：
Year: 2016 PMID： 26859083
Source DB: PubMed Journal: Q J Nucl Med Mol Imaging ISSN： 1824-4785 Impact factor: 2.346